Doxercalciferol Capsules 0 — Class III drug recall D-0651-2017
Terminated recall by West-Ward Columbus, Inc., reported 2017-04-19. Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
| Recall number | D-0651-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-Ward Columbus, Inc., Columbus, OH, United States |
| Recall initiated | 2017-04-04 |
| Classified | 2017-04-07 |
| Reported by FDA | 2017-04-19 |
| Terminated | 2018-09-04 |
| Countries outside the US | CA, MX |
| Quantity | 100 bottles |
| NDC | 00054-0338-19 |
| Lot numbers | KB60707 |
Product
Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19
Reason for recall
Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0651-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.